$0.2985
0.00060.2%
Last update: Nov 11, 9:02 AM
Mereo BioPharma Group PLC
MREONASDAQ
The average analyst price target for Mereo BioPharma Group is $4.58, 1434.3% above the current price. Of 8 analysts, 5 rate it Buy, 2 Hold and 1 Sell. Targets range from $0.50 to $8. The latest change came on Aug 19, 2026, when JP Morgan downgraded Mereo BioPharma Group from Neutral to Underweight.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
